Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.54
-0.14 (-1.82%)
At close: Nov 13, 2026, 4:00 PM EST
7.41
-0.13 (-1.72%)
Pre-market: Nov 16, 2026, 8:12 AM EST

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $45.85M in the quarter ending September 30, 2026, with 10.14% growth. This brings the company's total for the last twelve months to $213.00M, up 10.68% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. That makes Maravai LifeSciences Holdings the 17,059th largest company in the world by revenue and 2,839th in the United States.

Revenue (ttm)
$213.00M
Revenue Growth
+10.68%
P/S Ratio
9.20
Revenue / Employee
$519,502
Employees
410
Market Cap
1.96B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • TriLink 119.79M 64.5%
  • Cygnus 65.96M 35.5%

By Geography

Chart
  • North America 112.38M 60.5%
  • Asia Pacific 41.47M 22.3%
  • Europe, The Middle East and Africa 30.92M 16.6%
  • Latin and Central America 971.00K 0.5%
Fiscal year ended Dec 31, 2025 See the full MRVI breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.